Home/Filings/4/0001209191-21-035750
4//SEC Filing

Alafi Christopher D 4

Accession 0001209191-21-035750

CIK 0001567514other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 6:02 PM ET

Size

10.2 KB

Accession

0001209191-21-035750

Insider Transaction Report

Form 4
Period: 2021-05-21
Alafi Christopher D
Director10% Owner
Transactions
  • Sale

    Common Stock

    2021-05-21$40.00/sh1,100$44,000168,900 total(indirect: By Trust)
  • Sale

    Common Stock

    2021-05-24$40.47/sh26,575$1,075,490142,325 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By LLC)
    4,743,770
  • Common Stock

    346,795
  • Common Stock

    (indirect: By Trust)
    503,753
Footnotes (5)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
  • [F2]Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.06 to $40.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
  • [F5]Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.

Issuer

Intra-Cellular Therapies, Inc.

CIK 0001567514

Entity typeother

Related Parties

1
  • filerCIK 0001299430

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 6:02 PM ET
Size
10.2 KB